Patents by Inventor Ruifa Mi

Ruifa Mi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC ELECTROSPUN FIBER COMPOSITIONS
    Publication number: 20180263919
    Abstract: The instant invention provides electrospun fiber compositions comprising one or more polymers and one or more biologically active agents. In specific embodiments, the biologically active agents are nerve growth factors. In certain embodiments, the electrospun fiber compositions comprising one or more biologically active agents are on the surface of a film, or a tube. The tubes comprising the electrospun fiber compositions of the invention can be used, for example, as nerve guide conduits.
    Type: Application
    Filed: March 9, 2018
    Publication date: September 20, 2018
    Inventors: Ahmet Hoke, Sing Y. Chew, Ruifa Mi, Kam W. Leong
  • THERAPEUTIC ELECTROSPUN FIBER COMPOSITIONS
    Publication number: 20170304214
    Abstract: The instant invention provides electrospun fiber compositions comprising one or more polymers and one or more biologically active agents. In specific embodiments, the biologically active agents are nerve growth factors. In certain embodiments, the electrospun fiber compositions comprising one or more biologically active agents are on the surface of a film, or a tube. The tubes comprising the electrospun fiber compositions of the invention can be used, for example, as nerve guide conduits.
    Type: Application
    Filed: April 26, 2017
    Publication date: October 26, 2017
    Inventors: Ahmet Hoke, Sing Y. Chew, Ruifa Mi, Kam W. Leong
  • THERAPEUTIC ELECTROSPUN FIBER COMPOSITIONS
    Publication number: 20150142026
    Abstract: The instant invention provides electrospun fiber compositions comprising one or more polymers and one or more biologically active agents. In specific embodiments, the biologically active agents are nerve growth factors. In certain embodiments, the electrospun fiber compositions comprising one or more biologically active agents are on the surface of a film, or a tube. The tubes comprising the electrospun fiber compositions of the invention can be used, for example, as nerve guide conduits.
    Type: Application
    Filed: January 26, 2015
    Publication date: May 21, 2015
    Inventors: Ahmet Hoke, Sing Y. Chew, Ruifa Mi, Kam W. Leong
  • THERAPEUTIC ELECTROSPUN FIBER COMPOSITIONS
    Publication number: 20140271793
    Abstract: The instant invention provides electrospun fiber compositions comprising one or more polymers and one or more biologically active agents. In specific embodiments, the biologically active agents are nerve growth factors. In certain embodiments, the electrospun fiber compositions comprising one or more biologically active agents are on the surface of a film, or a tube. The tubes comprising the electrospun fiber compositions of the invention can be used, for example, as nerve guide conduits.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: The Johns Hopkins University
    Inventors: Ahmet Hoke, Sing Y. Chew, Ruifa Mi, Kam W. Leong
  • Therapeutic Electrospun Fiber Compositions
    Publication number: 20100303881
    Abstract: The instant invention provides electrospun fiber compositions comprising one or more polymers and one or more biologically active agents. In specific embodiments, the biologically active agents are nerve growth factors. In certain embodiments, the electrospun fiber compositions comprising one or more biologically active agents are on the surface of a film, or a tube. The tubes comprising the electrospun fiber compositions of the invention can be used, for example, as nerve guide conduits.
    Type: Application
    Filed: May 4, 2006
    Publication date: December 2, 2010
    Applicant: The John Hopkins University
    Inventors: Ahmet Hoke, Kam W. Leong, Sing Yian Chew, Ruifa Mi
  • TREATMENT OF DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM
    Publication number: 20070275926
    Abstract: Pleiotrophin is used to treat various conditions, disorders, and diseases which involve damage to the peripheral nervous system. Such conditions include traumatic nerve damage, Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, spinobulbar muscular atrophy, spinal muscular atrophy, diabetic neuropathy, and uremic neuropathy. Pleiotrophin can be provided as a protein or as a gene therapy to a patient in need thereof.
    Type: Application
    Filed: May 22, 2007
    Publication date: November 29, 2007
    Applicant: The Johns Hopkins University
    Inventors: AHMET HOKE, RUIFA MI
  • Treatment for disorders of the peripheral nervous system
    Publication number: 20060122116
    Abstract: Pleiotrophin is used to treat various conditions, disorders, and diseases which involve damage to the peripheral nervous system. Such conditions include traumatic nerve damage, Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, spinobulbar muscular atrophy, spinal muscular atrophy, diabetic neuropathy, and uremic neuropathy. Pleiotrophin can be provided as a protein or as a gene therapy to a patient in need thereof.
    Type: Application
    Filed: November 1, 2005
    Publication date: June 8, 2006
    Applicant: The Johns Hopkins University
    Inventors: Ahmet Hoke, Ruifa Mi